Wall Street is positive on Inovio Pharmaceuticals Inc (INO). On average, analysts give INO a Hold rating. The average price target is $1.333, which means analysts expect the stock to gain by 166.60% over the next twelve months.
That average ranking earns INO an Analyst Rating of 4, which is better than 4% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating INO a Hold today. Find out what this means to you and get the rest of the rankings on INO!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Inovio Pharmaceuticals Inc Stock Today?
Inovio Pharmaceuticals Inc (INO) stock is unchanged -0.99% while the S&P 500 has risen 0.1% as of 9:50 AM on Friday, Jun 16. INO is flat $0.00 from the previous closing price of $0.51 on volume of 998,527 shares. Over the past year the S&P 500 has gained 20.82% while INO is lower by -66.22%. INO lost -$0.99 per share the over the last 12 months.
Click Here to get the full Stock Report for Inovio Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
